US Cardiac Implants Market

http://www.reportlinker.com/p096399/US-Cardiac-Implants-Market.html

US demand to reach $16.4 billion in 2012

US demand for cardiac implants will increase 8.8 percent annually to $16.4 billion in 2012. Evolving demographic and epidemiological patterns, along with the introduction of new and improved products, will promote growth. Based on aging population trends, the number of persons afflicted with one or more heart conditions is forecast to reach 73 million in 2012, up 1.7 percent per year from 2007. Implants are more effective than pharmaceuticals in treating, managing or preventing such cardiovascular disorders as arrhythmias, congestive heart failure, myocardial infarction, peripheral artery disease, stroke and valvular heart disease.

The market for cardiac implants is expected to recover from a sharp decline in coronary drug-eluting stent sales that began in mid-2006 and continued into the fourth quarter of 2007. This decline was due to a number of reports that linked the devices to a slightly greater risk of thrombosis in some post-angioplasty patients. Although the reported risk was only onehalf of one percent greater than for heart patients who received alternative therapies (i.e., angioplasty with bare-metal stents, coronary bypass surgery, medications), it prompted many physicians to discontinue using drug-eluting stents. This trend will change as new generation drug-eluting stents with smaller struts and a greatly reduced risk of complications reach the market over the next year.

ICDs, CRT devices will remain dominant types

Cardiac implants extend into several product groups. Implantable cardioverter defibrillators (ICDs) and related cardiac resynchronization therapy (CRT) devices together with their accessories generate the largest demand, followed by various types of stents. These two product groups will continue to lead cardiac implant sales based on new product introductions, widening eligibility for private and public health insurance coverage, expanding numbers of new patients, and diminishing safety concerns. Providing the most effective therapy for bradycardia, pacemakers and accessories will continue to serve a large, expanding US market. However, growth opportunities for these devices will decelerate over the long term as they have already achieved a high level of market penetration.

Heart-related grafts will provide strong growth opportunities as improvements in stenting systems create new safe and effective devices for treating aortic aneurysms, peripheral arterial diseases and stroke. Demand for heart valves will benefit from advances in tissue engineering, which will improve the safety, performance and longevity of animalderived xenografts. Heart valve repair products, consisting of annuloplasty rings and bands, will also fare well in the marketplace as new cardiac diagnostics enable valvular heart diseases to be detected in earlier stages before complete valve replacement becomes necessary. Less favorably, strong growth in the market for tissue valves and valve repair products will be partially offset by decreasing sales of mechanical valves.

Demand for embolic protection devices will rise at a strong pace as many more heart patients undergo procedures that pose an elevated risk of deep vein thrombosis and embolisms. The market for ventricular-assist devices will continue to grow moderately, spurred by widening applications in the management of pretransplant and late-stage heart conditions. Based on their ability to detect heart attack symptoms earlier and save lives, implantable heart monitors will register strong sales growth over the long term.

Study coverage

Cardiac Implants is a new industry study that presents historical demand data (1997, 2002, 2007) plus forecasts for 2012 and 2017 for cardiac implant products by type and indication. The study also assesses evolving research and development, details company market shares and profiles 20 competitors in the US industry.

INTRODUCTIONI. EXECUTIVE SUMMARYII. MARKET ENVIRONMENTGeneralMacroeconomic TrendsDemographic PatternsHealth Insurance TrendsMedical ConditionsAcute ConditionsChronic ConditionsNational Health ExpendituresMedical ProvidersAcute Care HospitalsOutpatient ClinicsSkilled Nursing HomesPhysiciansHome Health Care OrganizationsPatient ActivityAcute Care Hospital AdmissionsSurgical ProceduresOutpatient EpisodesHome Health Care VisitsMedical Product MarketsIII. CARDIAC IMPLANT OVERVIEWGeneralCardiovascular ConditionsCoronary Heart DiseaseHeart Rhythm DisordersPeripheral Arterial Disease (PAD)Valvular Heart DiseaseStrokeCongestive Heart Failure (CHF)Congenital Heart DefectsCardiac Implant ProceduresCardiac Implant Market TrendsRegulatory FactorsDemand PatternsProduct GroupsIndicationsUS TradeInternational MarketsIV. PACING DEVICESGeneralDemand Patterns & ProjectionsProducers & Market ShareImplantable Cardioverter Defibrillators (ICDs)TechnologyComponents & DesignFunctionsClinical DataProducers & ProductsMedtronicBoston ScientificSt. Jude MedicalCardiac Resynchronization Therapy (CRT) DevicesTechnologyProducers & ProductsImplantable Cardiac Pacemakers (ICPs)TechnologyProducers & ProductsMedtronicSt. Jude MedicalBoston ScientificPacing LeadsTechnologyProducers & ProductsPacemaker LeadsICD LeadsCRT LeadsPacing Device BatteriesV. CARDIAC STENTS & RELATED IMPLANTSGeneralDemand Patterns & ProjectionsProducers & Market ShareCoronary StentsDrug-Eluting StentsBare-Metal StentsPeripheral StentsEndovascular Stent-GraftsMedtronicANCUREOther Endovascular Stent-GraftsRenal & Related StentsFemoral & Related StentsCarotid StentsStent-Related ImplantsSynthetic GraftsVascular GraftsPeripheral GraftsVena Cava FiltersVI. STRUCTURAL CARDIAC IMPLANTSGeneralDemand Patterns & ProjectionsProducers & Market ShareHeart Valves & AccessoriesProduct OverviewTissue Heart ValvesTypes of Tissue Heart ValvesProducers & ProductsMechanical Heart ValvesDesignProducers & ProductsHeart Valve Repair ProductsVentricular-Assist DevicesTechnologyProducers & ProductsImplantable Heart MonitorsInsertable Loop Recorders (ILRs)Implantable Hemodynamic MonitorsVII. INDUSTRY STRUCTUREGeneralMarket ShareCompetitive StrategiesMergers & AcquisitionsLicensing & Related AgreementsResearch & DevelopmentMarketing & DistributionManufacturing ActivitiesCompany ProfilesAbbott LaboratoriesAbiomed IncorporatedAngiotech Pharmaceuticals IncorporatedArbor Surgical Technologies IncorporatedBard (CR) IncorporatedBiophan Technologies IncorporatedBoston Scientific CorporationBraun (B.) Melsungen AGCarboMedics Incorporated, see Sorin SpAConor Medsystems LLC, see Johnson & JohnsonCook Group IncorporatedCordis Corporation, see Johnson & JohnsonCore Valve IncorporatedEdwards Lifesciences CorporationEndologix IncorporatedGore (WL) & Associates IncorporatedJohnson & JohnsonMedtronic IncorporatedMyotech LLC, see Biophan Technologies IncorporatedSorin SpASt. Jude Medical IncorporatedTerumo CorporationThoratec CorporationVentracor LimitedLIST OF TABLESSECTION I -- EXECUTIVE SUMMARYSummary TableSECTION II -- MARKET ENVIRONMENT1 Macroeconomic Indicators2 Population by Age Group3 Health Insurance Coverage of the US Population4 Acute Conditions by Type5 Chronic Conditions by Type6 National Health Expenditures by Type & Source7 Medical Providers by Type8 Patient Activity by Type9 Medical Product DemandSECTION III -- CARDIAC IMPLANT OVERVIEW1 Cardiac Implant Market Indicators2 Cardiovascular Conditions by Type3 Cardiac Implant Procedures by Type4 Cardiac Implant Market, 1997-20075 Cardiac Implant Demand by Product Group6 Cardiac Implant Demand by Indication7 US Trade in Cardiac Implants8 World Cardiac Implant Demand by RegionSECTION IV -- PACING DEVICES1 Pacing Device Demand by Product Group2 Implantable Cardioverter Defibrillator (ICD) Demand by Type3 Cardiac Resynchronization Therapy (CRT) Device Demand4 Implantable Cardiac Pacemaker Demand by Type5 Pacing Lead Demand by TypeSECTION V -- STENTS & RELATED IMPLANTS1 Cardiac Stent & Related Implant Demand by Product Group2 Coronary Stent Demand by Type3 Coronary Drug-Eluting Stent Demand4 Coronary Bare-Metal Stent Demand5 Peripheral Stent Demand by Product Group6 Endovascular Stent-Graft Demand7 Renal & Related Stent Demand8 Femoral & Related Stent Demand9 Carotid Stent Demand10 Stent-Related Implant Demand by Product GroupSECTION VI -- STRUCTURAL CARDIAC IMPLANTS1 Structural Cardiac Implant Demand by Product Group2 Heart Valve Implant Demand by Product Group3 Ventricular Assist Device Demand4 Implantable Heart Monitor DemandSECTION VII -- INDUSTRY STRUCTURE1 Cardiac Implant Sales by Company, 20072 Selected Acquisitions & Divestitures3 Selected Cooperative AgreementsLIST OF CHARTSSECTION III -- CARDIAC IMPLANT OVERVIEW1 Cardiovascular Conditions by Type, 20072 Cardiac Implant Procedures by Type, 20073 Cardiac Implant Demand by Product Group, 20074 Cardiac Implant Demand by Indication, 2007SECTION IV -- PACING DEVICES1 Pacing Device Demand by Product Group, 20072 Pacing Devices Market Share by Company, 2007SECTION V -- STENTS & RELATED IMPLANTS1 Stent & Stent-Related Implant Demand by Product Group, 20072 Stents & Stent-Related Implant Market Share by Company, 2007SECTION VI -- STRUCTURAL CARDIAC IMPLANTS1 Structural Cardiac Implant Demand by Product Group, 20072 Structural Cardiac Implant Market Share by Company, 2007SECTION VII -- INDUSTRY STRUCTURE1 US Cardiac Implants, Market Share by Company, 2007To order this report:

US Cardiac Implants Market

http://www.reportlinker.com/p096399/US-Cardiac-Implants-Market.html

More market research reports here!

Contacts:Reportlinker.comNicolasUS: (805) 652-2626 or Intl: +1-805-652-2626Email: nbo@reportlinker.com